Effect of empagliflozin versus linagliptin on body composition in Asian patients with type 2 diabetes treated with premixed insulin
Crossref DOI link: https://doi.org/10.1038/s41598-022-21486-9
Published Online: 2022-10-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zeng, Yi-Hong
Liu, Sung-Chen
Lee, Chun-Chuan
Sun, Fang-Ju
Liu, Jason J.
Text and Data Mining valid from 2022-10-12
Version of Record valid from 2022-10-12
Article History
Received: 21 November 2021
Accepted: 27 September 2022
First Online: 12 October 2022
Competing interests
: The authors declare no competing interests.